India has recently concluded the pan-India 1000 genome sequencing of SARS-CoV-2. This can completely revolutionize the understanding of the mechanisms behind COVID-19. The article below provides insights into the research. The Union Health Minister has recently announced the successful completion of the pan-India 1000 genome sequencing of SARS-CoV-2. This is a major milestone in the fight against COVID-19, as the sequencing project can provide crucial insights into the pathophysiology and genetics of SARS-CoV-2.
Interesting results are being expected from the research. What is the Pan-India 1000 Genome Sequencing of SARS-Cov-2? On May 1, 2020, the Department of Biotechnology (DBT), India, had undertaken a project involving sequencing a total of 1000 SARS-CoV-2 genomes obtained from different samples. The aims were to: Decipher the infectivity and pathophysiology of SARS-CoV-2.…
